knowledge -WSS

knowledge

author：Wikipedia 2025-09-06 05:03:35 - browse：1

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke.

He is also trying to fight the long legacy of racism in neuroscience. During 2020, when it was difficult to conduct research, he said, “I got the chance and the ability to read more widely and to just look into the legacy of neuroscience.” He found a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black people’s hair can sometimes exclude them from clinical trials because electrodes are not designed for them. In 2021, he co-founded Black in Neuro, an organization dedicated to improving Black representation in neuroscience.

On this episode of the “First Opinion Podcast,” I spoke to him about how the past and present racism in neuroscience could be reflected in the future, especially as neurotechnology like brain implants become more common.

“I’m not saying that whatever electrode that you made or created is racist. But when you have someone who … creates a technology but doesn’t think about the wide range of users that are potentially going to use it, then that’s where the problem comes in,” he told me.

We also discussed the way inequities in neuroscience research are visible in stroke wards, how brain implants might jump from helping disabled people to being used for human enhancement, and more.

Our conversation was inspired by his recent First Opinion essay, “Neuroscience has to grapple with a long legacy of racism if it wants to move into the future.” The book I mention at the end is “Lock In” by John Scalzi, a great sci-fi mystery exploring themes of race, socioeconomic status, neurotechnology, and more.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Elevance, SCAN deals highlight health insurer acquisition scrutiny

WSS

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

FDA warns medical device makers about rise in fabricated data

Weight loss drugs aren’t covered by Obamacare. That may change

Flagship Pioneering startup Sonata Therapeutics lays off 21

The stock market has soared this year, but will it last? Experts weigh in

Researchers tackle phage therapy hurdles for wider adoption

focus

knowledge

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

leisure time

Jerome Adams on the need for new antivirals for Covid

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

FDA approval of Sarepta Duchenne genetic therapy gives me hope

After a decade, new Gardasil ad campaign gets it (mostly) right

Psychedelics group wrestles with new pharma identity

Ukraine seeks to reclaim its role as a hub for clinical trials

Guidelines to prevent youth baseball injuries need more muscle

Telehealth startups are trying to fill the menopause care vacuum

Cancer drug shortages should be causing more outrage

The stock market has soared this year, but will it last? Experts weigh in

hotspot

Medicare Advantage enrollment grows 7.1% to 33.4 million people

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Caribou posts encouraging results on off

Judge denies Trump's request for new trial in E. Jean Carroll case

'CMA Fest' 2023: How to watch, who is performing and more

knowledge

hotspot

focus

Wikipedia